 selected.
The balance of risks vs benefits for individual early
thrombus removal strategies are further discussed below.
Less rigorous evidence suggests that the optimal patient population includes patients with a first episode of
iliofemoral DVT of ‚¨ç14 days in duration, having a reasonable life expectancy, and without a high risk of bleeding.
Recommendations regarding the optimal patient population are largely derived from one large, multicenter registry
of patients undergoing catheter-directed pharmacologic

JOURNAL OF V